Shah SS - Search Results

1

Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancer.

Shah SS, Ketterling RP, Goetz MP, Ingle JN, Reynolds CA, Perez EA, Chen B. Shah SS, et al. Hum Pathol. 2010 Jan;41(1):103-6. doi: 10.1016/j.humpath.2009.07.001. Epub 2009 Sep 16. Hum Pathol. 2010. PMID: 19762065

2

Testing for HER2 in Breast Cancer: A Continuing Evolution.

Shah S, Chen B. Shah S, et al. Patholog Res Int. 2010 Dec 6;2011:903202. doi: 10.4061/2011/903202. Patholog Res Int. 2010. PMID: 21188214 Free PMC article.

3

Amyloidosis of the breast: predominantly AL type and over half have concurrent breast hematologic disorders.

Said SM, Reynolds C, Jimenez RE, Chen B, Vrana JA, Theis JD, Dogan A, Shah SS. Said SM, et al. Among authors: shah ss. Mod Pathol. 2013 Feb;26(2):232-8. doi: 10.1038/modpathol.2012.167. Epub 2012 Sep 28. Mod Pathol. 2013. PMID: 23018872 Free article.

4

Interobserver variability by pathologists in the distinction between cellular fibroadenomas and phyllodes tumors.

Lawton TJ, Acs G, Argani P, Farshid G, Gilcrease M, Goldstein N, Koerner F, Rowe JJ, Sanders M, Shah SS, Reynolds C. Lawton TJ, et al. Among authors: shah ss. Int J Surg Pathol. 2014 Dec;22(8):695-8. doi: 10.1177/1066896914548763. Epub 2014 Aug 26. Int J Surg Pathol. 2014. PMID: 25161205 Free PMC article.

5

ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer.

Reese JM, Suman VJ, Subramaniam M, Wu X, Negron V, Gingery A, Pitel KS, Shah SS, Cunliffe HE, McCullough AE, Pockaj BA, Couch FJ, Olson JE, Reynolds C, Lingle WL, Spelsberg TC, Goetz MP, Ingle JN, Hawse JR. Reese JM, et al. Among authors: shah ss. BMC Cancer. 2014 Oct 7;14:749. doi: 10.1186/1471-2407-14-749. BMC Cancer. 2014. PMID: 25288324 Free PMC article.

6

Preoperative axillary imaging with percutaneous lymph node biopsy is valuable in the contemporary management of patients with breast cancer.

Hieken TJ, Trull BC, Boughey JC, Jones KN, Reynolds CA, Shah SS, Glazebrook KN. Hieken TJ, et al. Among authors: shah ss. Surgery. 2013 Oct;154(4):831-8; discussion 838-40. doi: 10.1016/j.surg.2013.07.017. Surgery. 2013. PMID: 24074422

7

Pure tubular carcinoma and axillary nodal metastases.

Fedko MG, Scow JS, Shah SS, Reynolds C, Degnim AC, Jakub JW, Boughey JC. Fedko MG, et al. Among authors: shah ss. Ann Surg Oncol. 2010 Oct;17 Suppl 3:338-42. doi: 10.1245/s10434-010-1254-2. Epub 2010 Sep 19. Ann Surg Oncol. 2010. PMID: 20853056

8

Arginase-1 is frequently positive in hepatoid adenocarcinomas.

Chandan VS, Shah SS, Torbenson MS, Wu TT. Chandan VS, et al. Among authors: shah ss. Hum Pathol. 2016 Sep;55:11-6. doi: 10.1016/j.humpath.2016.04.008. Epub 2016 Apr 30. Hum Pathol. 2016. PMID: 27137985

9

Aberrant CDX2 expression in hepatocellular carcinomas: an important diagnostic pitfall.

Shah SS, Wu TT, Torbenson MS, Chandan VS. Shah SS, et al. Hum Pathol. 2017 Jun;64:13-18. doi: 10.1016/j.humpath.2016.12.029. Epub 2017 Jan 13. Hum Pathol. 2017. PMID: 28089540

10

A subset of well-differentiated hepatocellular carcinomas are Arginase-1 negative.

Clark I, Shah SS, Moreira R, Graham RP, Wu TT, Torbenson MS, Chandan V. Clark I, et al. Among authors: shah ss. Hum Pathol. 2017 Nov;69:90-95. doi: 10.1016/j.humpath.2017.09.007. Epub 2017 Sep 29. Hum Pathol. 2017. PMID: 28970136

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,265 results

Search Page

Filters